Qube Research & Technologies (QRT)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-883,125
| Closed | -$61.3M | – | 3073 |
|
|
2025
Q1 | $61.3M | Buy |
883,125
+27,983
| +3% | +$1.94M | 0.07% | 244 |
|
|
2024
Q4 | $73.6M | Buy |
855,142
+192,899
| +29% | +$16.6M | 0.1% | 210 |
|
|
2024
Q3 | $78.9M | Sell |
662,243
-64,399
| -9% | -$7.67M | 0.12% | 161 |
|
|
2024
Q2 | $104M | Buy |
726,642
+6,511
| +0.9% | +$929K | 0.16% | 126 |
|
|
2024
Q1 | $92.5M | Buy |
720,131
+362,361
| +101% | +$46.5M | 0.15% | 156 |
|
|
2023
Q4 | $37M | Sell |
357,770
-236,554
| -40% | -$24.5M | 0.07% | 294 |
|
|
2023
Q3 | $54M | Buy |
594,324
+288,252
| +94% | +$26.2M | 0.14% | 175 |
|
|
2023
Q2 | $24.8M | Buy |
+306,072
| New | +$24.8M | 0.09% | 271 |
|
|
2022
Q4 | – | Sell |
-99,716
| Closed | -$4.97M | – | 2769 |
|
|
2022
Q3 | $4.97M | Sell |
99,716
-115,796
| -54% | -$5.77M | 0.03% | 579 |
|
|
2022
Q2 | $12M | Buy |
+215,512
| New | +$12M | 0.09% | 271 |
|
|
2022
Q1 | – | Sell |
-5,108
| Closed | -$286K | – | 2814 |
|
|
2021
Q4 | $286K | Sell |
5,108
-117,842
| -96% | -$6.6M | ﹤0.01% | 1825 |
|
|
2021
Q3 | $5.9M | Buy |
+122,950
| New | +$5.9M | 0.07% | 348 |
|
|
2021
Q2 | – | Sell |
-72,718
| Closed | -$2.45M | – | 2632 |
|
|
2021
Q1 | $2.45M | Sell |
72,718
-27,256
| -27% | -$919K | 0.04% | 566 |
|
|
2020
Q4 | $3.49M | Sell |
99,974
-29,510
| -23% | -$1.03M | 0.05% | 415 |
|
|
2020
Q3 | $4.5M | Sell |
129,484
-46,360
| -26% | -$1.61M | 0.06% | 389 |
|
|
2020
Q2 | $5.76M | Buy |
+175,844
| New | +$5.76M | 0.08% | 305 |
|
|
2020
Q1 | – | Sell |
-24,714
| Closed | -$715K | – | 1486 |
|
|
2019
Q4 | $715K | Sell |
24,714
-7,770
| -24% | -$225K | 0.02% | 774 |
|
|
2019
Q3 | $840K | Buy |
+32,484
| New | +$840K | 0.56% | 46 |
|
|
2018
Q2 | – | Sell |
-98
| Closed | -$2K | – | 898 |
|
|
2018
Q1 | $2K | Buy |
+98
| New | +$2K | ﹤0.01% | 326 |
|